Synereca Pharmaceuticals
Oklahoma City, US · Delaware corporation
Find your way into Synereca Pharmaceuticals
Sign up to see every warm intro you have to Synereca Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Synereca Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BW
Bennett W. LoveNamed on SEC filing
CI
Clayton I. DuncanNamed on SEC filing
SF
Scott F. SingletonNamed on SEC filing
MC
Mark CorriganNamed on SEC filing
RE
Richard E. GammansNamed on SEC filing
SM
Scott MeachamNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$600K disclosed across 1 round · 2017
▶$600KraisedAug 2017 · 10 investors · Other Health CareRule 506(b)
▶$600KraisedAug 2017 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bennett W. LoveDirector
- Clayton I. DuncanExecutive Officer, Director
- Scott F. SingletonDirector
- Mark CorriganDirector
- Richard E. GammansExecutive Officer, Promoter
- Scott MeachamDirector
- Offering amount
- $1.2M
- Amount sold
- $600K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Synereca Pharmaceuticals raised?
- Synereca Pharmaceuticals has disclosed $600K raised across 1 round.
- Where is Synereca Pharmaceuticals headquartered?
- Synereca Pharmaceuticals is headquartered in Oklahoma City, US.